GlassScriptPhysician profile
Gil Kimchi
NPI 1689355448
$9,297.44
in general payments reported to CMS, 2019-2025
4 companies · $3,133 in 2025
The $3,133 reported for 2025 was more than what 75% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $454 · 2024: $5,711 · 2025: $3,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,602 · Consulting Fee: $2,600 · Food and Beverage: $2,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,601.66 |
| Consulting Fee | $2,600.00 |
| Food and Beverage | $2,095.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $5,975.61 | 2024-2025 | Icotec Blackarmor Spine System, Vader Pedicle System, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm |
| Medtronic, INC. | $2,770.00 | 2023-2024 | Mazor X System, Infinity Occipitocervical Upper Thoracic System |
| Nuvasive, INC. | $283.62 | 2023 | Simplify Cervical Artificial Disc, Xlif |
| Globus Medical, INC. | $268.21 | 2024 | Altera, Captivate Vl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gil Kimchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.